Photodynamic therapy: An innovative approach to the treatment of keloid disease evaluated using subjective and objective non-invasive tools

Archives of Dermatological Research

Volumn 305, Issue 3, 2013, Pages 205-214

  Ud Din, Sara ^a,b   Thomas, Grace ^a,b   Morris, Julie ^c   Bayat, Ardeshir ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Field therapy; Keloid disease; Methyl aminolevulinic acid; Photodynamic therapy; Scar treatments

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; COLLAGEN; HEMOGLOBIN; MELANIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; EXCISION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; KELOID; MALE; NON INVASIVE MEASUREMENT; PAIN; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; SCAR FORMATION; SCORING SYSTEM;

AMINOLEVULINIC ACID; COLLAGEN; FEMALE; HEMOGLOBINS; HUMANS; KELOID; MALE; MELANINS; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRURITUS; TREATMENT OUTCOME;

EID: 84876477650     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1295-4     Document Type: Article

References (46)

1. Aarabi S, Bhatt K, Shi Y, Paterno J, Chang E, Loh S, Holmes J, Longaker M, Yee H, Gurtner G (2007) Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB 21:3250-3261
2. Akaishi S, Ogawa R, Hyakusoku H (2008) Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses 71:32-38
3. Atilli SK, Lesar A, Mcneill A, Camacho-Lopez M, Moseley H, Ibbotson S, Samuel ID, Ferguson J (2009) An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. BJD 161:170-173
4. Bayat A, Arscott G, Ollier W, Ferguson MWJ, McGrouther DA (2003) 'Aggressive keloid': a severe variant of familial keloid scarring. J R Soc Med 96:554-555
5. Bock O, Schmid-Ott G, Malewski P, Mrowietz U (2006) Quality of life with keloid and hypertrophic scarring. Arch Derm Res 297:433-443
6. Boehncke WH (2000) Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch Dermatol 136:271-272
7. Braakhuis BJM, Tabor MP, Kummer A, Leemans CR, Brakenhoff RH (2003) A genetic explanation of slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63:1727-1730
8. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA (2005) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Am Acad Dermatol 56:125-143
9. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049-1058
10. Brown B, McKenna S, Solomon M, Wilburn J, McGrouther DA, Bayat A (2010) The patient-reported impact of scars measure: development and validation. Plast Reconstr Surg 125:1439-1449
11. Brown BC, Moss TP, McGrouther DA, Bayat A (2010) Skin scar preconceptions must be challenged: importance of self-perception in skin scarring. J Plast Reconstr Aesthet Surg 63:1022-1029
12. Bruscino N, Lotti T, Rossi R (2011) Photodynamic therapy for a hypertrophic scarring: a promising choice. Photodermatol Photoimmunol Photomed 27:334-335
13. Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006 Part 1: photochemistry and photobiology. JEADV 21:293-302
14. Campbell SM, Tyrrell J, Marshall R, Curnow A (2010) Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther 7:183-188
15. Chiu LL, Sun CH, Yeh AT, Torkian B, Karamzadeh A, Tromberg B, Wong BJ (2005) Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med 37:231-244
16. Christensen E, Warloe T, Kroon S, Funk J, Helsing P, Soler AM, Stang HJ, Vante O, Mork C (2010) Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. JEADV 24:505-512
17. Dienus K, Bayat A, Gilmore BF, Seifert O (2010) Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Arch Dermatol Res 302:725-731
18. Durani P, Bayat A (2008) Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg 61:4-17
19. Froelich K, Staudenmaier R, Kleinsasser N, Hagen R (2007) Therapy of auricular keloids: a review of different treatment modalities and proposal for a therapeutic algorithm. Eur Arch Otorhino 264:1497-7508
20. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113-125
21. Gulleth Y, Goldberg N, Silverman RP, Gastman BR (2010) What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg 126:1222-1231
22. Halim AS, Emami A, Salahshourifar I, Kannan TP (2012) Keloid scarring: understanding the genetic basis, advances, and prospects. Arch Plast Surg 39:184-189
23. Hollywood KA, Maatje M, Shadi IT, Henderson A, McGrouther DA (2010) Phenotypic profiling of keloid scars using FT-IR microspectroscopy reveals a unique spectral signature. Arch Dermatol Res 302:705-715
24. Iqbal SA, Sidgwick GP, Bayat A (2012) Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring. Arch Dermatol Res 304:665-671
25. Iqbal SA, Syed F, McGrouther DA, Paus R, Bayat A (2010) Differential distribution of haematopoietic and nonhaematopoietic progenitor cells in intralesional and extralesional keloid: do keloid scars provide a niche for nonhaematopoietic mesenchymal stem cells? Br J Dermatol 162:1377-1383
26. Javad F, Day PJ (2012) Protein profiling of keloidal scar tissue. Arch Dermatol Res 304:533-540
27. Karrer S, Abels C, Landthaler M, Szeimes RM (2000) Topical photodynamic therapy for localised scleroderma. Acta Derm Venereol 80:26-27
28. Karrer S, Bosserhoff A, Weiderer P, Landthaler M, Szeimies RM (2003) Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 120:325-331
29. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM (2004) Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J of Derm 151:776-783
30. King KM, McFetridge-Durdle J, LeBlanc P, Anzarut A, Tsuyuki RT (2008) A descriptive examination of the impact of sternal scar formation in women. Eur J Cardiovasc Nurs 8:112-118
31. Lau K, Paus R, Tiede S, Day P, Bayat A (2009) Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol 18:921-933
32. Li X, Zhou ZP, Hu L, Zhang WJ, Li W (2012) Apoptotic cell death induced by 5-aminolevulinic acid-mediated photodynamic therapy of hypertrophic scar-derived fibroblasts. J Dermatolog Treat [Epub ahead of print]
33. Mendoza J, Sebastian A, Allan E, Allan D, Mandal P, Alonso-Rasgado T, Bayat A (2012) Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion. Arch Dermatol Res 304:549-562
34. Mrowietz U, Seifert O (2009) Keloid scarring: new treatments ahead. Actas Dermosifiliogr 100:75-83
35. Nie Z, Bayat A, Behzad F, Rhodes L (2010) Positive response of a recurrent keloid scar to topical methyl aminolevulinate-photodynamic therapy. Photodermatol Photoimmunol Photomed 26:330-332
36. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE (2001) Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 62:140-145
37. Seifert O, Mrowietz U (2009) Keloid Scarring: bench and bedside. Arch Dermatol Res 301:259-272
38. Shih B, Bayat A (2012) Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res 304:241-249
39. Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319-339
40. Shih B, Garside E, McGrouther DA, Bayat A (2010) Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Rep Regen 18:139-153
41. Simon R, Eltze E, Scafer KL, Burger H, Semjonow A, Hertle L, Dokhorn-Dworniczak B, Terpe HJ, Bocker W (2001) Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intra epithelial spread of tumour cells. Cancer Res 61:332-355
42. Slaughter DP, Southwick HW, Smejkal W (1953) "Field cancerization" in oral stratified squamous epithelium. Cancer 6:963-968
43. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A (2010) Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III expression compared to intra- and extra-lesional sites: clinical implications for lesional site-directed therapy. BJD 164:83-96
44. Tabor MP, Brakenhoff RH, Ruijter-Scippers HJ, van der Wal JE, Snow GB, Leemans CR, Braakhuis BJM (2002) Multiple head and neck tumours frequently originate from a single preneoplastic lesion. Am J Pathol 161:1051-1060
45. Tan K, Shah N, Pritchard S, McGrouther DA, Bayat A (2010) The influence of surgical excision margins on keloid prognosis. Ann Plas Surg 64:55-58
46. Vincent AS, Phan TT, Mukhopadhyay A, Lim HY, Halliwell B, Wong KP (2008) Human skin keloid fibroblasts display bioenergetics of cancer cells. J Investig Dermatol 128:702-709